| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 76.03B | 88.51B | 76.08B | 64.10B | 52.69B | 86.93B |
| Gross Profit | 70.44B | 85.36B | 66.16B | 54.42B | 35.33B | 69.99B |
| EBITDA | 4.84B | 24.45B | 7.04B | 37.92B | 16.63B | 34.35B |
| Net Income | -5.68B | 10.91B | -5.83B | 12.51B | 3.39B | 13.02B |
Balance Sheet | ||||||
| Total Assets | 718.74B | 746.77B | 709.64B | 761.64B | 1.50T | 1.61T |
| Cash, Cash Equivalents and Short-Term Investments | 404.54B | 431.35B | 53.47B | 97.94B | 181.02B | 261.30B |
| Total Debt | 105.61B | 57.73B | 87.02B | 100.16B | 594.56B | 585.65B |
| Total Liabilities | 598.65B | 616.80B | 583.39B | 628.52B | 1.40T | 1.50T |
| Stockholders Equity | 117.99B | 126.40B | 123.98B | 131.71B | 99.64B | 104.29B |
Cash Flow | ||||||
| Free Cash Flow | -15.64B | 935.00M | 8.73B | 1.36B | -38.78B | 45.09B |
| Operating Cash Flow | -15.34B | 1.46B | 13.30B | 8.05B | -30.98B | 51.70B |
| Investing Cash Flow | -20.66B | -19.47B | -32.18B | -86.35B | -21.87B | -6.03B |
| Financing Cash Flow | -11.69B | -108.00M | -25.19B | -5.11B | -34.16B | 13.76B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥87.03B | 7.80 | ― | 5.75% | 30.59% | 55.29% | |
70 Outperform | ¥202.87B | 7.69 | ― | 4.01% | 21.03% | 85.36% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | ¥2.02T | 10.14 | 9.37% | 4.13% | 6.95% | 15.03% | |
65 Neutral | ¥251.91B | 15.69 | 14.00% | 5.13% | 34.33% | 47.34% | |
59 Neutral | ¥3.70T | 11.81 | 10.23% | 3.93% | 0.46% | 6.87% | |
56 Neutral | ¥168.57B | 14.51 | 7.26% | 4.16% | 46.50% | ― |